Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-28

Clinical Trial Update: Anecortave Acetate in Patients With Open-angle Glaucoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating anecortave acetate in patients with open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma | Phase 2 | Status: COMPLETED